ArticleCureus2016

Relapsed High-Risk Medulloblastoma: Stable Disease after Two Years of Treatment with Somatostatin Analog - Case Report.

Luisa Galvis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.